Delving into the Latest Updates on Kurobe Pharmaceuticals, Inc. with Synapse

概览

关联

1

项与 Kurobe Pharmaceuticals, Inc. 相关的临床试验

NCT02432807

/ Completed临床3期

A Randomized, Multicenter, Double-Masked, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Vancomycin Hydrochloride Ophthalmic Ointment 1.1% in Patients With Moderate to Severe Bacterial Conjunctivitis

This is a Phase 3 study to evaluate the safety and efficacy of a vancomycin hydrochloride ophthalmic ointment dosed 4 times daily for 7 days compared to placebo (vehicle) in patients with moderate to severed Gram-positive bacterial conjunctivitis.

开始日期2015-05-01

申办/合作机构

Kurobe Pharmaceuticals, Inc.

100 项与 Kurobe Pharmaceuticals, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Kurobe Pharmaceuticals, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Kurobe Pharmaceuticals, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Kurobe Pharmaceuticals, Inc. 相关的转化医学

登录后查看更多信息